Inherited hormone-pathway variants flagged prostate cancers likely to turn lethal

Design

Prospective multi-institutional cohort with germline genotyping and functional studies

Population

1,926 men with localized prostate cancer (median follow-up 9.8 years)

Primary outcome

Association of steroidogenic germline variants with progression and mortality

Effect

Variants in SRD5A2, HSD17B2, CYP1B1 nominally linked to lethal disease; combined markers most predictive

Predicting which localized prostate cancers will progress to incurable disease is still imperfect. This prospective cohort of 1,926 men with localized prostate cancer examined 22 germline variants across 10 steroidogenic genes against circulating hormones and long-term outcomes, over a median 9.8 years.

Several variants — in SRD5A2, HSD17B2 and CYP1B1 — were nominally associated with progression to lethal disease, and combining markers predicted time to metastasis, castration resistance and death better than any single variant. Some variants plausibly altered gene transcription or protein levels in laboratory models, offering a mechanism via androgen metabolism.

This is early, hypothesis-generating work: the associations are nominal and unreplicated, and nothing here is a test to order. Its value is direction — germline hormone-pathway markers may eventually sharpen inherited risk stratification beyond current clinical and somatic tools, which would help decide who needs intensified surveillance or treatment.

• Germline variants in SRD5A2, HSD17B2 and CYP1B1 were nominally associated with progression to lethal prostate cancer.
• A combination of markers predicted metastasis, castration resistance and death better than single variants.
• Some variants altered transcription or protein expression in laboratory models, suggesting a hormonal mechanism.
• This is not a clinical test — treat it as an early signal toward inherited risk stratification.

Why it matters

It points toward a non-invasive, inherited way to flag the localized cancers most likely to become lethal.

Don't overread it

Nominal, single-cohort associations without replication — this cannot yet guide an individual patient's management.

The statistics, in plain English

'Nominal' associations are those significant before correcting for the many comparisons made, so some may be chance; that a combined marker panel outperformed single variants is encouraging but still needs independent replication.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.